Compare Allbirds Inc (BIRD) vs Bristol-Myers Squibb Co (BMY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Allbirds Inc vs Bristol-Myers Squibb Co — how do they compare? Allbirds Inc trades at $2.59 (market cap $30.00M), while Bristol-Myers Squibb Co trades at $63.7 (market cap $129.94B). The key difference: Bristol-Myers Squibb Co is far larger — about 4331.3× Allbirds Inc's market cap, and Bristol-Myers Squibb Co pays a 3.96% dividend while Allbirds Inc pays none. Which is the better fit depends on your goals.
| BIRD | BMY | |
|---|---|---|
Market Cap | $30.00M | $129.94B |
Sector | Consumer Cyclical | Health |
52-Week High | $16.99 | $65.89 |
52-Week Low | $2.21 | $42.60 |
Enterprise Value | $48.86M | $163.92B |
Dividend Yield | — | 3.96% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Allbirds Inc
Allbirds Inc is a global lifestyle brand that innovates with naturally derived materials to make footwear and apparel products. Its primary source of revenue is from sales of shoes and apparel products in its directly owned digital and physical retail channels.
Read more on BIRD →About Bristol-Myers Squibb Co
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →
